🕵️ Pelthos Therapeutics Inc. ($PTHS)
SEC insider & ownership activity, last 12 months · CIK 1919246 · every row links its SEC filing
Over the last 12 months insiders sold $441K against $1000K of open-market buying. Todd C. Davis bought $1000K in discretionary trades (Jun). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $1000K (2 lots) · 5 sellers, $441K (21 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Todd C. Davis | 2 | $1000K | 0 | – | Jun 11, 2026 |
| Ezra M. Friedberg | 0 | – | 10 | $314K | Jul 2, 2026 |
| Francis Knuettel II | 0 | – | 1 | $40K | May 22, 2026 |
| Peter Greenleaf | 0 | – | 4 | $37K | Jul 2, 2026 |
| Pauls Matthew | 0 | – | 4 | $37K | Jul 2, 2026 |
| Malamut Richard | 0 | – | 2 | $12K | Apr 2, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | 49.9% | 13D | Nov 6, 2025 | filing ↗ | |
| 3I, LP | 9.9% | 13G | May 7, 2026 | filing ↗ | |
| 3I Management LLC | 9.9% | 13G | May 7, 2026 | filing ↗ | |
| Maier Joshua Tarlow | 9.9% | 13G | May 7, 2026 | filing ↗ | |
| Alexandra Wood (CANADA) Inc. | 9.5% | 13G | Jan 15, 2025 | filing ↗ | |
| Murchinson Ltd. | 9.1% | 13G | Nov 14, 2025 | filing ↗ | |
| Marc Bistricer | 9.1% | 13G | Nov 14, 2025 | filing ↗ | |
| Ezra Friedberg | 8.3% | 13D | Jul 1, 2025 | filing ↗ | |
| Ikarian Capital, LLC | 7.7% | 13G | May 15, 2026 | filing ↗ | |
| Neil Shahrestani | 7.7% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Francis Knuettel II | $47K | May 22, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | May 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 28, 2026 | filing ↗ |
| Auditor change (4.01) | May 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 14, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 10, 2026 | filing ↗ |
| Earnings (2.02) | Mar 19, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 19, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 12, 2026 | filing ↗ |
| New financial obligation (2.03) | Jan 12, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 6, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 23, 2025 | filing ↗ |
| Other events (8.01) | Dec 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 23, 2025 | filing ↗ |
| Officer/director changes (5.02) | Dec 23, 2025 | filing ↗ |
| Other events (8.01) | Dec 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 23, 2025 | filing ↗ |
| Shareholder vote (5.07) | Dec 17, 2025 | filing ↗ |